Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

NGX:NEIMETH Balance Sheet

Financials in millions NGN. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Sep 30, 2022
Cash & Equivalents	1,188	1,555	2,147	2,429	448.37	810.49
Cash & Short-Term Investments	1,188	1,555	2,147	2,429	448.37	810.49
Cash Growth	-33.83%	-27.57%	-11.63%	441.78%	-44.68%	-59.98%
Accounts Receivable	1,375	1,025	1,272	757.72	1,299	1,209
Other Receivables	-0.88	317.01	344.14	-	-	-
Receivables	1,374	1,342	1,616	803.82	1,355	1,264
Inventory	3,711	3,894	1,868	2,106	1,719	1,732
Prepaid Expenses	106.45	109.64	50.61	40.6	21.46	103.93
Other Current Assets	85.08	64.59	52.78	34.42	77.99	41.39
Total Current Assets	6,464	6,966	5,735	5,414	3,622	3,951
Property, Plant & Equipment	4,618	4,263	4,209	3,665	2,855	2,436
Other Intangible Assets	5.79	9.5	19	-	-	-
Other Long-Term Assets	2,776	2,776	2,025	1,101	34.01	34.23
Total Assets	13,864	14,014	11,987	10,179	6,512	6,422

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Sep 30, 2022
Accounts Payable	888.32	396.88	168.62	117.5	113.09	94.65
Accrued Expenses	-	351.78	3,990	2,197	998.55	762.98
Short-Term Debt	-	-	201.99	176.35	-	913.16
Current Portion of Long-Term Debt	2,845	2,653	4,859	3,883	2,158	1,096
Current Portion of Leases	-	10.52	28.79	40.64	-	-
Current Income Taxes Payable	104.4	111.43	87.23	68.82	86.77	103.92
Current Unearned Revenue	78.61	78.61	90.02	406.71	119.04	76.93
Other Current Liabilities	0	210.46	192.61	255.2	154.51	149.7
Total Current Liabilities	3,916	3,812	9,618	7,145	3,630	3,198
Long-Term Debt	6,493	6,955	294.67	288.18	1,487	1,322
Long-Term Unearned Revenue	238.07	238.07	316.69	102.51	509.21	702.17
Long-Term Deferred Tax Liabilities	380.52	380.52	106.23	106.23	106.23	106.23
Total Liabilities	11,028	11,386	10,336	7,642	5,733	5,328

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Sep 30, 2022
Common Stock	2,137	2,137	2,137	2,137	949.58	949.58
Additional Paid-In Capital	2,378	2,378	2,378	2,378	8.82	27.38
Retained Earnings	-1,678	-1,886	-2,863	-1,977	-179.63	117
Shareholders' Equity	2,836	2,628	1,652	2,537	778.77	1,094
Total Liabilities & Equity	13,864	14,014	11,987	10,179	6,512	6,422

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Sep 30, 2022
Total Debt	9,338	9,618	5,385	4,388	3,645	3,331
Net Cash (Debt)	-8,150	-8,063	-3,238	-1,959	-3,197	-2,521
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.91	-1.89	-0.76	-0.46	-1.68	-1.33
Filing Date Shares Outstanding	4,273	4,273	4,273	4,273	1,899	1,899
Total Common Shares Outstanding	4,273	4,273	4,273	4,273	1,899	1,899
Working Capital	2,549	3,154	-3,883	-1,732	-7.53	753.78
Book Value Per Share	0.66	0.62	0.39	0.59	0.41	0.58
Tangible Book Value	2,830	2,619	1,633	2,537	778.77	1,094
Tangible Book Value Per Share	0.66	0.61	0.38	0.59	0.41	0.58
Land	85.87	85.87	85.87	85.87	85.87	85.87
Buildings	365.82	346.52	253.44	183.63	165.75	163.68
Machinery	2,996	2,649	1,931	1,804	1,930	1,833
Construction In Progress	2,901	2,832	3,440	2,966	1,883	1,538

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 15, 2026

Data Sources Report a data error